Crismab SA
Crismab reported total assets of 18,117 € at the end of the 2024 financial year (annual accounts filed with the NBB on 29 Sep 2025).
The score of Crismab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Total assets -89 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Crismab's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 01 Oct 2024
- Year ended 31 Dec 2022filed on 09 Aug 2023
- Year ended 31 Dec 2021filed on 15 Nov 2022
- Year ended 31 Dec 2020filed on 29 Oct 2021
Crismab's financial analysis
- Solvency-3981.5%sector median: 28.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Crismab
Crismab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0862.379.191
- VAT number
- BE0862379191
- Peppol
- Registered · 0208:0862379191 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 23 Dec 2003
- Registered office
- 4530 Villers-le-Bouillet
- Latest accounts
- 2024 · filed on 29 Sep 2025
- Activity
- Retail sale of chocolate and sugar confectionery (NACE 47242)
Crismab (SA) has been based in Villers-le-Bouillet since 2003, active in: retail sale of chocolate and sugar confectionery. For 2024, it reports a net loss of 720 € and equity of −721,327 €; its revenue is not published. Its solvency stands at -3981.5%, below the median of its sector (28.9%).
Companies similar to Crismab
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about Crismab
What is the revenue of Crismab?
Crismab files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Crismab?
In Belgium, the VAT number is the company number prefixed with BE: BE0862379191 for Crismab, if the company is VAT-registered. Its company number (CBE) is 0862.379.191.
Where is the registered office of Crismab?
According to the CBE register, the registered office of Crismab is in 4530 Villers-le-Bouillet.
What is the equity of Crismab?
At the close of the 2024 financial year, the equity of Crismab amounts to -721,327 €, a solvency of -3981.5% of total assets.
Who manages Crismab?
The register lists 5 active mandates at Crismab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Crismab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →